PI11263 Uracil (CAS No.: 66-22-8)

Catalogue Number	PI11263
Purity	≥ 99%
CAS Number	66-22-8
Form	Powder

Uracil is an organic heterocycle that serves as a pharmaceutical intermediate in various synthesis processes. Stanford Advanced Materials (SAM) produces this compound using controlled crystallisation methods and analytical verification employing HPLC to confirm its purity. SAM's process includes batch-specific quality assessments to ensure consistent physicochemical properties, thereby supporting precise reaction conditions in chemical and pharmaceutical laboratories.

INQUIRY

Description

Specification

Reviews

FAQ

What purity level is achieved for Uracil in SAM’s processing method?

SAM employs controlled recrystallisation and HPLC analysis to quantify and maintain the purity of Uracil. This method reduces impurity levels, ensuring that rigorous standards are met for pharmaceutical synthesis applications.

How does the powder form of Uracil impact its handling in synthesis procedures?

The powdered form enhances reaction kinetics due to its high surface area. However, it requires storage under controlled humidity to prevent clumping and moisture absorption, ensuring consistent performance during chemical reactions.

Are there customisation options available for Uracil specifications?

Yes, production batches and packaging configurations can be tailored based on specific synthesis requirements. Detailed production parameters can be adjusted following direct discussions to align with precise laboratory or industrial processes.

REQUEST A QUOTE

Send us an inquiry today to learn more and receive the latest pricing. Thank you!